Mar 27, 2017 - Allergan's lock-up of 100M in Teva shares expires in August.I dig into AGN's SEC filings to find out if the company plans to sell the shares immediately after the lock-up expires.After concluding that
Mar 24, 2017 - According to recent reports, Teva Pharmaceutical Industries Ltd (TEVA) is likely lay off almost 11% of its global workforce to cut costs and improve growth prospects.
Mar 23, 2017 - Allergan plc (AGN) recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S.
Mar 23, 2017 - Teva Pharmaceutical (NYSE:TEVA) plans to cut as many as 6,000 jobs, or about 11% of its global workforce, Israel's Calcalist reports.It has had a rough year, with a serious of costly acquisitions, alo
Mar 21, 2017 - Allergan plc (AGN) announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21.
Mar 21, 2017 - Nektar Therapeutics??? (NKTR) shares surged 42.6% after the company announced positive results from a phase III efficacy study evaluating its investigational candidate, NKTR-181, in patients with moderate to severe chronic low back pain.
Mar 20, 2017 - London based AstraZeneca plc (AZN) received a second Complete Response Letter (CRL) from the FDA for its new drug application (NDA) for investigational drug ZS-9.
Mar 17, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) recently launched an authorized generic version of Allergan plc???s (AGN) oral contraceptive, Minastrin 24 Fe1, in the U.S.
Mar 10, 2017 - Welcome to your weekly digest of approaching regulatory and clinical readouts. Teva (NYSE:TEVA) expects a US decision on SD-809, its possible treatment for Huntington’s chorea, at the beginning of Apr
Feb 15, 2017 - Teva's joint venture with long-time Japanese OTC drug company Takeda began during 2016.The joint venture added $450M in generics revenue during the 4th Quarter of 2016.TEVA looks set to continue growi